Estimating the economic impact of a possible equine and human epidemic of west nile virus infection in Belgium

Eurosurveillance

Volumn 21, Issue 31, 2016, Pages

  Humblet, M ^a   Vandeputte, S ^a   Fecher Bourgeois, F ^a   Leonard P ^b   Gosset, C ^a   Balenghien, T ^c,d   Durand, B ^e   Saegerman, Claude ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CIRAD   (France)

^d CEMAGREF   (France)

^e UNIVERSITÉ PARIS EST   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COST OF ILLNESS; CULEX PIPIENS; EMPLOYMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; HEALTH INSURANCE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFECTION RATE; MALE; MEDICAL DECISION MAKING; MORBIDITY; NONHUMAN; POPULATION DENSITY; PUBLIC HEALTH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOCIOECONOMICS; VACCINATION; WEST NILE VIRUS; ANIMAL; ANIMAL HUSBANDRY; BELGIUM; CULEX; ECONOMICS; HORSE; HORSE DISEASES; ISOLATION AND PURIFICATION; PROSPECTIVE STUDY; VETERINARY; VIROLOGY; WEST NILE FEVER;

ANIMAL HUSBANDRY; ANIMALS; BELGIUM; CULEX; DISEASE OUTBREAKS; EPIDEMICS; FEMALE; HORSE DISEASES; HORSES; HUMANS; MALE; PROSPECTIVE STUDIES; VACCINATION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 85015356156     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.31.30309     Document Type: Article

References (62)

1. Hayes EB, Komar N, Nasci RS, Montgomery SP, O’Leary DR, Campbell GL. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005;11(8):1167-73. DOI: 10.3201/eid1108.050289a PMID: 16102302
2. Rossi SL, Ross TM, Evans JD. West Nile virus.Clin Lab Med. 2010;30(1):47-65. Error! Hyperlink reference not valid. DOI: 10.1016/j.cll.2009.10.006 PMID: 20513541
3. Brault AC. Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility. Vet Res. 2009;40(2):43. http://www.ncbi.nlm.nih.gov/pubmed/19406093 DOI: 10.1051/vetres/2009026 PMID: 19406093
4. Centre for Food Safety and Public Health (CFSPH)/Institute for International Cooperation in Animal Biologics. West Nile virus infection. 2013. Ames, IA: Iowa State University. [Accessed 18 Dec 2014]. Available from: http://www.cfsph.iastate.edu/Factsheets/pdfs/west_nile_fever.pdf
5. Leblond A, Hendrikx P, Sabatier P. West Nile virus outbreak detection using syndromic monitoring in horses. Vector Borne Zoonotic Dis. 2007;7(3):403-10. DOI: 10.1089/vbz.2006.0593 PMID: 17767410
6. Murray KO, Mertens E, Despres P. West Nile virus and its emergence in the United States of America. Vet Res 2010; 41:67 http://www.ncbi.nlm.nih.gov/pubmed/21188801
7. European Food Safety Agency (EFSA) and European Centre for Disease Prevention and Control. (ECDC). Information on specific zoonoses and zoonotic agents-West Nile virus. In: EU Summary report on zoonoses, zoonotic agents and food-borne outbreaks 2012. EFSA Journal 2014;12:3547.
8. Bournez L, Beck C, Troyano-Groux A, Lecollinet S. Short item. Reemergence of West Nile virus in South-Eastern France in 2015 and equine epizootics. Bull Epid Santé Anim Alim.2015;72:34-5.
9. Cnops L, Papa A, Lagra F, Weyers P, Meersman K, Patsouros N, et al. West Nile virus infection in Belgian traveler returning from Greece. Emerg Infect Dis. 2013;19(4):684-5. DOI: 10.3201/ eid1904.121594 PMID: 23762912
10. Balenghien T, Vazeille M, Grandadam M, Schaffner F, Zeller H, Reiter P, et al. Vector competence of some French Culex and Aedes mosquitoes for West Nile virus. Vector Borne Zoonotic Dis. 2008;8(5):589-95. DOI: 10.1089/vbz.2007.0266 PMID: 18447623
11. Engler O, Savini G, Papa A, Figuerola J, Groschup MH, Kampen H, et al. European surveillance for West Nile virus in mosquito populations. Int J Environ Res Public Health. 2013;10(10):4869-95. DOI: 10.3390/ijerph10104869 PMID: 24157510
12. Hanon JB, Uyttenhoef A, Fecher-Bourgeois F, Kirschvink N, Haubruge E, Duquesne B, et al. Estimation quantitative des pertes économiques directes et indirectes subies par les éleveurs Wallons dans le cadre de la fièvre catarrhale ovine (sérotype 8) durant la période 2006-2007. [Quantitative estimation of direct and indirect economic losses undergone by Walloon cattle holders within the framework of ovine catharral fever (serotype 8) between 2006 and 2007]. Epidémiol Santé Anim.2009;56:187-95. French.
13. Martinelle L, Dal Pozzo F, Gauthier B, Kirschvink N, Saegerman C. Field veterinary survey on clinical and economic impact of Schmallenberg virus in Belgium. Transbound Emerg Dis. 2014;61(3):285-8. DOI: 10.1111/tbed.12030 PMID: 23279714
14. Stirling A. Risk, precaution and science: towards a more constructive policy debate. Talking point on the precautionary principle. EMBO Rep. 2007;8(4):309-15. DOI: 10.1038/ sj.embor.7400953 PMID: 17401403
15. Stirling A. Science, precaution, and the politics of technological risk: converging implications in evolutionary and social scientific perspectives. Ann N Y Acad Sci. 2008;1128(1):95-110. DOI: 10.1196/annals.1399.011 PMID: 18469218
16. Byford S, Torgerson DJ, Raftery J. Economic note: cost of illness studies. BMJ. 2000;320(7245):1335. DOI: 10.1136/ bmj.320.7245.1335 PMID: 10807635
17. European Environment Agency (EEA). CLC2006 technical guidelines. No 17/2007. Copenhagen: EEA; 2007. Available from: http://www.eea.europa.eu/publications/technical_report_2007_17
18. Durand B, Lecollinet S, Beck C, Martínez-López B, Balenghien T, Chevalier V. Identification of hotspots in the European union for the introduction of four zoonotic arboviroses by live animal trade. PLoS One. 2013;8(7):e70000. http://www.ncbi.nlm.nih.gov/pubmed/23894573 DOI: 10.1371/journal.pone.0070000 PMID: 23894573
19. Federal Public Service (FPS) of Economy, Small and Medium Enterprises (SMEs), Self-employed and Energy. Population, chiffres population 2010-2014.[Population, Population figures 2010-2014]. Updated 17 Jul 2014. Belgium: FPS Economy, SMEs, Self-Employed and Energy. [Accessed 18 Dec 2014]. French. Available from: http://statbel.fgov.be/fr/modules/publications/statistiques/population/population_-_chiffres_population_2010_-_2012.jsp
20. Ndiva Mongoh M, Hearne R, Dyer NW, Khaitsa ML. The economic impact of West Nile virus infection in horses in the North Dakota equine industry in 2002. Trop Anim Health Prod. 2008;40(1):69-76. DOI: 10.1007/s11250-007-9055-8 PMID: 18551781
21. Mont-le-Soie European Horse Centre, Department of Rural Economy (University of Liege) and Unit of Economy and Rural Development, Gembloux Agro-Bio Tech (University of Liege). Le poids socio-économique de la filière équine en Wallonie. [The socio-economic importance of equine industry in Wallonia]. Grand Halleux: Centre Européen du Cheval; March 2010. [Accessed 18 Dec 2014]. [Accessed 1 Jul 2016]. French.
22. Durand B, Chevalier V, Pouillot R, Labie J, Marendat I, Murgue B, et al. West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey. Emerg Infect Dis. 2002;8(8):777-82. DOI: 10.3201/eid0808.010486 PMID: 12141961
23. Durand B, Dauphin G, Zeller H, Labie J, Schuffenecker I, Murri S, et al. Serosurvey for West Nile virus in horses in southern France. Vet Rec. 2005;157(22):711-3. DOI: 10.1136/vr.157.22.711 PMID: 16311385
24. Weese JS, Baird JD, DeLay J, Kenney DG, Staempfli HR, Viel L, et al. West Nile virus encephalomyelitis in horses in Ontario: 28 cases. Can Vet J. 2003; 44(6):469-73.
25. Murgue B, Murri S, Zientara S, Durand B, Durand JP, Zeller H. West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerg Infect Dis. 2001;7(4):692-6. DOI: 10.3201/eid0704.017417 PMID: 11585534
26. Genain JL, Grosbois F, Zientara S. Fièvre de West-Nile. [West Nile fever]. Saint-Contest: Réseau d’Epidémio-Surveillance en Pathologie Equine (RESPE); 2010. [Accessed 18 Dec 2014]. French. Available from: http://www.respe.net/system/ files/20100614_N_WestNile-GP.pdf
27. European Centre for Disease Prevention and Control (ECDC). West Nile fever. In: Annual epidemiological report 2014-emerging and vector-borne diseases. Stockholm: ECDC; 2014. p. 45-50. Available from: http://ecdc.europa.eu/ en/publications/_layouts/forms/Publication_DispForm. aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1196
28. Federal Agency for the Safety of the Food Chain (AFSCA). Scénario opérationnel pour la maladie due au virus West Nile ou fièvre du Nil Occidental. [Operational scenario for West Nile virus disease or West Nile Fever]. Brussels: AFSCA; 2009. [Accessed 18 Dec 2014]. French. Available from: http:// www.favv.be/santeanimale/fievreniloccidental/_documents/ ScenarioWNVv1.0_fr_20091201.pdf
29. Federal Ministry of Agriculture. 1er février 2012. Arrêté royal portant des mesures de police sanitaire relatives aux encéphalites virales des équidés. [1 February 2012. Royal decree on animal health measures in case of viral equine encephalitis]. 3 Jul 2012. Brussels: Federal Ministry of Justice. [Accessed 18 Dec 2014]. French. Available from: http://www.ejustice.just.fgov.be/cgi/api2. pl?lg=fr&pd=2012-03-07&numac=2012024081
30. Belgian Centre of Pharmacotherapeutics Information (CBIP). Virus de la fièvre du Nil occidental ou virus West Nile. [West Nile Fever virus or West Nile virus]. In: Répertoire Commenté des Médicaments à usage vétérinaire 2014. [Commented directory of veterinary drugs 2014]. Liege: CBIP; 2014. [Accessed 1 Jul 2016]. Available from: www.cbip-vet.be/fr/ texts/FEQOOOL1AL2o.php#WNV
31. French Agency for Food Health Security (AFSSA). Rapport sur la surveillance de l’infection à virus West Nile en France. [Report on the surveillance of West Nile virus infection in France]. Maisons-Alfort: AFSSA; 2004. [Accessed 18 Dec 2014]. French. Available from: http://www.ladocumentationfrancaise.fr/var/storage/rapports-publics/054000115/0000.pdf
32. Animal and Plant Health Inspection Service (APHIS), Veterinary services (Centers for Epidemiology and Animal Health). Economic Impact of West Nile Virus on the Colorado and Nebraska Equine Industries: 2002. Washington, DC: United States Department of Agriculture (USDA); 2003. [Accessed 18 Dec 2014]. Available from: http://www. aphis.usda.gov/animal_health/nahms/equine/downloads/ wnv2002_CO_NB.pdf
33. United States Centers for Disease Control and Prevention (CDC). West Nile virus. Atlanta, GA: CDC. [Accessed 18 Dec 2014]. Available from: http://www.cdc.gov/ncidod/dvbid/westnile/resources/FightTheBite_Factsheet/MediaTools/print/WNV%20media%20factsheet_natnl.pdf
34. European Centre for Disease Prevention and Control (ECDC). West Nile fever. Factsheet for health professionals. Stockholm: ECDC. [Accessed 24 Jun 2016]. Available from: http://ecdc. europa.eu/en/healthtopics/west_nile_fever/factsheet-forhealth-professionals/Pages/factsheet_health_professionals. aspx
35. Staples JE, Shankar MB, Sejvar JJ, Meltzer MI, Fischer M. Initial and long-term costs of patients hospitalized with West Nile virus disease. Am J Trop Med Hyg. 2014;90(3):402-9. DOI: 10.4269/ajtmh.13-0206 PMID: 24515937
36. Charrel RN, de Lamballerie X, Durand JP, Gallian P, Attoui H, Biagini P, et al. Prevalence of antibody against West Nile virus in volunteer blood donors living in southeastern France. Transfusion 2001;41:1320-1.
37. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358(9278):261-4. DOI: 10.1016/S0140-6736(01)05480-0 PMID: 11498211
38. Ladbury GA, Gavana M, Danis K, Papa A, Papamichail D, Mourelatos S, et al. Population seroprevalence study after a West Nile virus lineage 2 epidemic, Greece, 2010. PLoS One. 2013;8(11):e80432. DOI: 10.1371/journal.pone.0080432 PMID: 24260390
39. Danis K, Papa A, Theocharopoulos G, Dougas G, Athanasiou M, Detsis M, et al. Outbreak of West Nile virus infection in Greece, 2010. Emerg Infect Dis. 2011;17(10):1868-72. DOI: 10.3201/eid1710.110525 PMID: 22000357
40. Barber LM, Schleier JJ, Peterson RKD. Economic cost analysis of West Nile virus outbreak, Sacramento County, California, USA, 2005.Emerg Infect Dis. 2010;16(3):480-6. DOI: 10.3201/ eid1603.090667 PMID: 20202424
41. Gerkens S, Merkur S. Belgium: Health system review. Health Syst Transit. 2010;12(5):1-266, xxv. PMID: 21224177
42. Institut national d’assurance maladie-invalidité (INAMI). La nomenclature des prestations de santé. [Nomenclature of health services]. Updated 15 Jan 2015. Brussels: INAMI. [Accessed 18 Dec 2014]. French. Available from: http:// www.inami.fgov.be/fr/nomenclature/Pages/default.aspx#. VJPypP8JAk
43. Faudemer S, Pestieau P, Perelman S. (in French). Le prix de la vie: une approche ex post. [The price of life: an ex post approach]. Risques. 1994;19:117-32.
44. Humblet MF, Vandeputte S, Fecher-Bourgeois F, Léonard P, Gosset C, Balenghien T, et al. WNF associated costs for the equine sector-Scenario 1. Supplementary material. Liege: University of Liege; 2016. Available from: http://orbi.ulg. ac.be/retrieve/269218/20160714_Additional_Data_WNF_ Horses_8.5%25.pdf
45. Humblet MF, Vandeputte S, Fecher-Bourgeois F, Léonard P, Gosset C, Balenghien T, et al. WNF associated costs for the equine sector-Scenario 2. Supplementary material. Liege: University of Liege; 2016. Available from: http://orbi.ulg. ac.be/retrieve/269219/20160714_Additional_Data_WNF_ Horses_34%25.pdf
46. Humblet MF, Vandeputte S, Fecher-Bourgeois F, Léonard P, Gosset C, Balenghien T, et al. WNND/AFP associated costs/ losses in humans-2% infection rate scenario. Supplementary material. Liege: University of Liege; 2016. Available from: http://orbi.ulg.ac.be/retrieve/269220/20160714_Additional_ Data_WNF_Publ_Health_2%25.pdf
47. Humblet MF, Vandeputte S, Fecher-Bourgeois F, Léonard P, Gosset C, Balenghien T, et al. WNND/AFP associated costs/ losses in humans-15% infection rate. Supplementary material. Liege: University of Liege; 2016. Available from: http://orbi. ulg.ac.be/retrieve/269221/20160714_Additional_Data_WNF_ Publ_Health_15%25.pdf
48. Cabre O, Grandadam M, Marié JL, Gravier P, Prangé A, Santinelli Y, et al. West Nile virus in horses, sub-Saharan Africa. Emerg Infect Dis. 2006;12(12):1958-60. DOI: 10.3201/ eid1212.060042 PMID: 17326952
49. Gavlan R, Rene A, Bae S, Singh KP. An analytical study of the perceptions, prevention strategies, treatment and economic impact of equine West Nile virus. Proceedings of the 3rd International Conference on Agricultural Statistics (ICAS III); 2-4 Nov 2004. Cancún, México. [Accessed 1 Jul 2016]. Available from: https://www.nass.usda.gov/mexsai/Papers/westnilep. pdf
50. Federal Agency for the Safety of the Food Chain (AFSCA). Fièvre du Nil occidental (ou fièvre de West Nile). [West Nile Fever]. Updated 4 Apr 2015. Brussels: AFSCA. [Accessed 12 May 2015]. French. Available from: http://www.favv-afsca.be/ santeanimale/fievreniloccidental/default.asp#situation
51. Angenvoort J, Brault AC, Bowen RA, Groschup MH. West Nile viral infection of equids. Vet Microbiol. 2013;167(1-2):168-80. DOI: 10.1016/j.vetmic.2013.08.013 PMID: 24035480
52. World Organisation for Animal Health (OIE). West Nile fever. In: Terrestrial Animal Health Code (2016). Paris: OIE; 2016. Chapter 8.18. Available from: http://www.oie.int/fileadmin/Home/eng/ Health_standards/tahc/current/chapitre_wnf.pdf
53. Zohrabian A, Meltzer MI, Ratard R, Billah K, Molinari NA, Roy K, et al. West Nile virus economic impact, Louisiana, 2002. Emerg Infect Dis. 2004;10(10):1736-44. DOI: 10.3201/eid1010.030925 PMID: 15504258
54. Rizzoli A, JiménezClavero MA, Barzon L, Cordioli P, Figuerola J, Koraka P, et al. The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill. 2015; 20(20): pii: 21135. DOI: 10.2807/1560-7917. ES2015.20.20.21135 PMID: 26027485
55. Centers for Disease Control and Prevention (CDC). West Nile virus transmission via organ transplantation and blood transfusion-Louisiana, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(45):1263-7. Accessed12Jul2016. Available from: http:// www.cdc.gov/mmwr/preview/mmwrhtml/mm5845a3.htmPMID: 19940831
56. European Commission. Commission Directive 2014/110/EU of 17 December 2014 amending Directive 2004/33/EC as regards temporary deferral criteria for donors of allogeneic blood donations. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 20.12.2014 L 366. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/ PDF/?uri=CELEX:32014L0110&from=EN
57. Kelley WE, Bradley K, Duncan A, Smith J. Blood donor screening for West Nile virus in Oklahoma and its contribution to disease surveillance, 2003-2013. J Okla State Med Assoc. 2015;108(8):351-6. PMID: 27188096
58. Zohrabian A, Hayes EB, Petersen LR. Cost-effectiveness of West Nile virus vaccination. Emerg Infect Dis. 2006;12(3):375-80. DOI: 10.3201/eid1203.050782 PMID: 16704772
59. Coût journalier d’une infirmière. [Daily cost for a home nurse]. Brussels: National Institute of Health-Disabilities Insurance. [Accessed 1 Jul 2016]. French. Available from: http://www.inami.fgov.be/SiteCollectionDocuments/tarif_ infirmiers_20140101.pdf
60. Coût journalier pour un aide-soignant. [Daily cost for a caregiver]. Brussels: SETCa-BBTK BHV. [Accessed 1 Jul 2016]. French. Available from: www.aide-soignant.be/wp-content/ uploads/2014/01/Baremes_1.12.2012.pdf
61. Statistics Belgium. Le marché du travail en chiffres absolus. [Labour market in absolute terms]. Brussels: Statistics Belgium. [Accessed 1 Jul 2016]. French. Available from: http:// statbel.fgov.be/fr/statistiques/chiffres/travailvie/emploi/ chiffres/
62. Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Ewing D, Mazowiecki M, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11(7):1021-7. DOI: 10.3201/ eid1107.040991 PMID: 16022775